Infectious Diseases
Conference Coverage
Switch to integrase inhibitor regimen safe and effective
Forty-eight weeks after the switch, virologic suppression was maintained among 94.3% of those on an integrase inhibitor–based regimen.
Conference Coverage
Islatravir + doravirine maintains HIV viral suppression
ISL+DOR appeared to be “well tolerated,” according to the investigators.
News
C. difficile linked to surgery risk in pediatric Crohn’s
Patients who tested positive for Clostridoides difficile in the first year after diagnosis were more likely to go in for colectomy.
Feature
What’s in a number? 697,633 children with COVID-19
Already-low hospitalization and death rates among children are getting lower.
From the Journals
Flu vaccine significantly cuts pediatric hospitalizations
More than half (58%) of hospitalized children had underlying medical conditions and 38% had at least one hospitalization in the past year.
From the Journals
‘Profound human toll’ in excess deaths from COVID-19 calculated in two studies
The number of deaths caused by the pandemic exceeds publicly reported COVID-19 death counts by 20%.
From the Journals
HPV vaccination remains below Healthy People goals despite increases
HPV vaccination among U.S. adolescents has increased in the last decade but varies at state level.
Letters from Maine
Returning to competition
Dr. Wilkoff muses on the effect of the pandemic on school sports.
From the Journals
Remdesivir effective, well-tolerated in final trial report
A 50% greater likelihood of significant clinical improvement within 15 days occurs with taking remdesivir versus placebo.
Conference Coverage
COVID-19 vaccine hesitancy ‘somewhat understandable,’ expert says
Dr. Offit predicts a vaccine may be able to be 75%-80% effective at preventing mild to moderate disease.
Feature
One measure of child COVID-19 may be trending downward
Percentage of weekly cases occurring in children has dropped for 2 consecutive weeks.